KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Amortization - Intangibles (2020 - 2024)

Vir Biotechnology's Amortization - Intangibles history spans 5 years, with the latest figure at $18.8 million for Q2 2024.

  • For Q2 2024, Amortization - Intangibles fell 18.12% year-over-year to $18.8 million; the TTM value through Jun 2024 reached $82.8 million, up 18.57%, while the annual FY2023 figure was $87.0 million, 209.66% up from the prior year.
  • Amortization - Intangibles for Q2 2024 was $18.8 million at Vir Biotechnology, down from $21.3 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $23.0 million in Q2 2023 and bottomed at -$32000.0 in Q3 2020.
  • The 5-year median for Amortization - Intangibles is $2.0 million (2020), against an average of $8.8 million.
  • The largest annual shift saw Amortization - Intangibles tumbled 90.66% in 2021 before it soared 84736.36% in 2022.
  • A 5-year view of Amortization - Intangibles shows it stood at $288000.0 in 2020, then tumbled by 42.01% to $167000.0 in 2021, then soared by 9583.83% to $16.2 million in 2022, then increased by 28.22% to $20.7 million in 2023, then decreased by 9.11% to $18.8 million in 2024.
  • Per Business Quant, the three most recent readings for VIR's Amortization - Intangibles are $18.8 million (Q2 2024), $21.3 million (Q1 2024), and $20.7 million (Q4 2023).